Clinical Trial Update: 3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ziprasidone with lithium or divalproex for acutely manic bipolar disorder has completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Divalproex (divalproex sodium)
• Lithium (Lithium carbonate)
• Ziprasidone (ziprasidone)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED | Results posted: 2010-01-22